In patients with COPD, there were a decrease in symptom
scores and a decrease in the rate of exacerbations in the fluticasone
arm in the unique study that used endobronchial biopsies
(27). Nevertheless, no relationships were found between biopsy
results and clinical outcomes. These findings call into question
the relevance of the bronchial inflammatory infiltrate to the
clinical and functional pattern in COPD.